Contera Pharma A/S

Contera Pharma identifies and develops innovative treatments for patients suffering from neurological disorders. Contera Pharma’s science is based on a precision medicine approach integrating external and internal data sources to support rational ID & selection of human disease-validated drug discovery targets to identify novel pipeline opportunities.

The company uses expertise in neuroscience drug discovery and development, in close collaboration with expert individuals and organizations, to accelerate R&D activities.

Contact name:

Anders Brandt Elvang


DTU Science Park, Agern Allé 24, 2970 Hørsholm, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

Copyright 2011 DANISH BIO – DANSK BIOTEK. All rights reserved.